A Study of Quintuple Therapy to Treat COVID-19 Infection
Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
This is a Phase II interventional study will test the efficacy of quintuple therapy
(Hydroxychloroquine, Azithromycin, Vitamin C, Vitamin D, and Zinc) in the treatment of
patients with COVID-19 infection).
Phase:
Phase 2
Details
Lead Sponsor:
ProgenaBiome
Collaborator:
DSCS CRO
Treatments:
Ascorbic Acid Azithromycin Hydroxychloroquine Vitamin D Vitamins